Browse > Article
http://dx.doi.org/10.5012/bkcs.2011.32.12.4352

4D-QSAR Study of p56Ick Protein Tyrosine Kinase Inhibitory Activity of Flavonoid Derivatives Using MCET Method  

Yilmaz, Hayriye (Erciyes University, Faculty of Pharmacy)
Guzel, Yahya (Erciyes University, Faculty of Science, Department of Chemistry)
Onal, Zulbiye (Erciyes University, Faculty of Science, Department of Chemistry)
Altiparmak, Gokce (Erciyes University, Faculty of Science, Department of Chemistry)
Kocakaya, Safak Ozhan (University of Dicle, Faculty of Science, Department of Chemistry)
Publication Information
Abstract
A four dimensional quantitative structure activity relationship analysis was applied to a series of 50 flavonoid inhibitors of $p56^{lck}$ protein tyrosine kinase by the molecular comparative electron topological method. It was found that the -log (IC50) values of the compounds were highly dependent on the topology, size and electrostatic character of the substituents at seven positions of the flavonoid scaffold in this study. Depending on the negative or positive charge of the groups correctly embedded in these substituents, three-dimensional bio-structure to increase or decrease -log (IC50) values in the training set of 39 compounds was predicted. The test set of 11 compounds was used to evaluate the predictivity of the model. To generate 4D-QSAR model, the defined function groups and pharmacophore used as topological descriptors in the calculation of activity were of sufficient statistical quality ($R^2$ = 0.72 and $Q^2$ = 0.69). Ligand docking approach by using Dock 6.0. These compounds include many flavonoid analogs, They were docked onto human families of p56lck PTKs retrieved from the Protein Data Bank, 1lkl.pdb.
Keywords
Drug design; 4D-QSAR; Flavonoid; ETM; Protein tyrosine kinase;
Citations & Related Records

Times Cited By Web Of Science : 0  (Related Records In Web of Science)
Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Tjalling, J. Y. SIAM Review 1995, 37, 531.   DOI   ScienceOn
2 Melanie, M. MIT Press, London. 1999.
3 Cho, D. H.; Lee, S. K.; Kim, B. T.; No, K. T. Bull. Korean Chem. Soc. 2001, 22, 388.   과학기술학회마을
4 Hoskuldsson, A. J. Chemometrics 1988, 2, 211.   DOI
5 Efron, B. J. Am. Stat. Assoc. 1983, 78, 316.   DOI
6 Lang, P. T.; Moustakas, D.; Brozell, S.; Carrascal, N.; Mukherjee, S.; Pegg, S.; Raha, K.; Shivakumar, D.; Rizzo, R.; Case, D.; Shoichet, B.; Kuntz, I. 2007. DOCK 6.1, University of California, San Francisco. http://dock.compbio.ucsf.edu/
7 Case, D. A.; Cheatham III, T. E.; Darden, T.; Gohlke, H.; Luo, R.; Merz, K. M.; Onufriev, A. Jr.; Simmerling, C.; Wang, B.; Woods, R. The Amber biomolecular simulation programs. J. Computat. Chem. 2005, 26, 1668.   DOI   ScienceOn
8 Lee, M. R.; Duan, Y.; Kollman, P. A. Proteins: Struct. Funct., Genet. 2000, 39, 309.   DOI   ScienceOn
9 Srinavasan, J.; Cheatham, T. E.; Cieplak, P.; Kollman, P. A.; Case, D. A. J. Am. Chem. Soc. 1998, 120, 9401.   DOI   ScienceOn
10 Prasanna1, S.; Doerksen, R. J. Current Medicinal Chemistry 2009, 16, 21.   DOI   ScienceOn
11 Cheng, Z.; Zhang, Y.; Zhang, W. Med. Chem. Res. 2009, 16, 2479.
12 Kubinyi, H. Ed.ESCOM Science Publishers, Leiden, The Netherlands, 1993.
13 Gren, S. M.; Marshall, G. R. Trends Pharmacol. Sci. 1995, 16, 285.   DOI   ScienceOn
14 Hopfinger, A. J.; Tokarski, J. S., Charifson, P. S. Ed. Marcel Dekker: New York, 1997, p 106.
15 Crame, R. D.; Patterson, D. E.; Bunce, J. D. J. Am. Chem. Soc. 1988, 110, 5959.   DOI   ScienceOn
16 Hopfinger, A. J.; Wang S.; Tokarski, J. S.; Jin, B.; Albuquerque, M.; Madhav, P. J.; Duraiswami, C. J. Am. Chem. Soc. 1997, 119, 10509.   DOI   ScienceOn
17 Hopfinger, A. J.; Burke, B. J.; Dunn, W. J. J. Med. Chem. 1994, 37, 3768.   DOI   ScienceOn
18 SPARTAN '08 for Windows; Wavefunction, Inc.: Irvine, CA, USA, 2008.
19 Guzel, Y.; Ozturk, E. Bioorganic & Medicinal Chem. 2003, 11, 4383.   DOI   ScienceOn
20 Bersuker, I. B.; Dimoglo, A. S. Reviews in Computational Chemistry, Lipkowitz, K. B., Boyd, D. B., Eds; VCH: New-York, 1991.
21 Dimoglo, A. S.; Beda, A. A.; Shvets, N. M.; Gorbachov, M. Y.; Kheifits, L. A; Aulchenko, I. S. New. J. Chem. 1995, 19, 149.
22 Dimoglo, A. S.; Gorbachov, M. Y.; Bersuker, I. B.; Greni, A. I.; Vysotskaya, L. E.; Stepanova, O. V.; Lukash, E. Yu. Die Nahrung 1988, 32, 461.   DOI   ScienceOn
23 Guzel, Y. J. Molecular Structure 1996, 366, 131.   DOI   ScienceOn
24 Manning, G.; Whyte, D. B.; Martinez, R.; Hunter T.; Sudarsanam, S. Science 6 2002, 298, 1912.   DOI   ScienceOn
25 Bersuker, I. B.; Bahçeci, S.; Boggs, J. E.; Pearlman, R. S. SAR and QSAR in Env. 1999, 10, 157.   DOI   ScienceOn
26 Bersuker, I. B.; Bahceci, S.; Boggs, J. E.; Pearlman, R. S. J. Comput.-Aided Mol. Des. 1999, 13, 419.   DOI   ScienceOn
27 Cohen, P. Nature Reviews Drug Discovery 1 2002; p 309.
28 Dancey, J.; Sausville, E. A. Nature Reviews in Drug Discovery and Development 2003, 2, 296.   DOI   ScienceOn
29 Adams, J. L.; Badger, A. M.; Kumar, S.; Lee, J. C. Prog. Med. Chem. 2001, 38, 1.   DOI
30 Weil, R.; Veillette, A. Current Topics Micro. Immunol. 1996, 205, 63.   DOI
31 Anderson, S. J.; Levin, S. D.; Perlmutter, R. M. Adv. Immunol. 1994, 56, 151.   DOI
32 Novic, M.; Nikolovska-Coleska, Z.; Solmajer, T. J. Chem. Inf. Comput. Sci. 1997, 37, 990.   DOI   ScienceOn
33 Fasihsi, A.; Sabet, R. Int. J. Mol. Sci. 2008, 9, 1876.   DOI   ScienceOn
34 Cushman, M.; Nagarathnam, D.; Burg, D. L.; Geahlen, R. L. J. Med. Chem. 1991, 34, 798.   DOI
35 Cushman, M.; Zhu, H.; Geahlen, R. L.; Kraker, A. J. J. Med. Chem. 1994, 37, 3353.   DOI